title: Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation.
authors.forename: J M
authors.initials: JM
authors.lastname: Horacek
authors.forename: M
authors.initials: M
authors.lastname: Tichy
authors.forename: L
authors.initials: L
authors.lastname: Jebavy
authors.forename: M
authors.initials: M
authors.lastname: Ulrychova
authors.forename: R
authors.initials: R
authors.lastname: Pudil
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D024982:Glycogen Phosphorylase, Muscle Form / Q000378:metabolism*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D024982:Glycogen Phosphorylase, Muscle Form